Percorrer por autor "Muniz, Edvani Curti"
A mostrar 1 - 2 de 2
Resultados por página
Opções de ordenação
- Chitosan/collagen biomembrane loaded with 2,3-dihydrobenzofuran for the treatment of cutaneous LeishmaniasisPublication . Braz, Elton Marks Araujo; Silva, Solranny Carla Cavalcante Costa; Alves, Michel Muálem Moraes; Carvalho, Fernando Aécio Amorim; Magalhães, Rui; Osajima, Josy Anteveli; Silva, Durcilene Alves; Oliveira, Ana Leite; Muniz, Edvani Curti; Silva-Filho, Edson CavalcantiIn this work, chitosan/collagen-based membranes loaded with 2,3-dihydrobenzofuran (2,3-DHB) were developed through a simple solvent-casting procedure for use in the treatment of cutaneous Leishmaniasis. The obtained membranes were characterized by elemental analysis, FTIR, TG, DSC, and XRD. Porosity, swelling, mechanical properties, hydrophilicity, and antioxidant activity were analyzed. In addition, assessment to the biocompatibility, through fibroblasts/keratinocytes and in vitro wound healing essays were performed. The obtained results show that the new 2,3-DHB loaded chitosan/collagen membrane presented high porosity and swelling capacity as well as maximum strength, hydrophilicity, and antioxidant activity higher in relation to the control. The tests of antileishmanial activity and the AFM images demonstrate great efficacy of inhibition growth of the parasite, superior to those from the standard therapeutic agent that is currently used: Amphotericin B. The new membranes are biocompatible and stimulated the proliferation of keratinocytes. SEM images clearly demonstrate that fibroblasts were able to adhere, maintained their characteristic morphology. The healing test evidenced that the membranes have adequate environment for promoting cell proliferation and growth. As the conventional treatments often use drugs with high toxicity, the as-developed new membranes proved to be excellent candidate to treat cutaneous Leishmaniasis and can be clearly indicated for further advanced studies in vivo.
- Emerging applications of Sterculia striata gum in medical, pharmaceutical, and environmental fields: prospects and challengesPublication . Freitas, Alessandra Ribeiro; Ribeiro, António José; Santos, Pauline Sousa dos; Oliveira, Thaísa Cardoso de; Oliveira, Jabson Herber Profiro de; Osajima, Josy A.; Ribeiro, Alessandra Braga; Veiga, Francisco; Bezerra, Roosevelt D.S.; Silva, Albert S.; Soares-Sobrinho, José Lamartine; Muniz, Edvani Curti; Silva-Filho, Edson C.Trees of the genus Sterculia produce acidic polysaccharides with high viscosity and the ability to form gels in water. This work emphasized the species Sterculia striata and the uses of its plant derivatives, such as seeds, fruits, stem bark, and exudates. The species showed prospects for industrial application (seeds with high protein content, fruits with antioxidant potential, and stem bark with anti-inflammatory, antinociceptive, and gastroprotective potential). From a physicochemical and rheological point of view, the exudate has a high molar mass value; it contains uronic acid, galactose, rhamnose, and xylose. Sterculia striata gum (SSG) is highly viscous in solution and can form thermoreversible gels where gelation conditions depend on the purification method, acetyl groups, and presence of salt. Due to the presence of carboxylic acid groups, polyanionic behaving SSG allow the formation of polyelectrolyte complexes, which have been used in drug delivery systems (DDS) to encapsulate drugs such as antimalarial drugs, improve essential oil stability and obtain films for antimicrobial purposes. This review contributes to the understanding of the use of this biomaterial, providing a basis for new research on its different applications and industrial use, with a focus on the pharmaceutical, medical, food, and environmental fields.